In a panel comparing other potential imaging targets (EGFR, HER2, GLUT1 and others), IGF-1R was found to be suitable for molecular imaging strategies in 80% of female and 77% of male breast tumors [102,103]. The gene discussed is ERBB2; the disease is breast neoplasm.